TABLE 2

Age at testing, time taken to receive test results and number of visits to doctor before referral stratified by primary ciliary dyskinesia (PCD) status for survey participants

TotalPCD disease status
PositiveNegativeInconclusiveOther#
Subjects365 (100)271 (74.3)18 (4.9)29 (8.0)47 (12.9)
Age at initial testing years
 <142 (11.5)30 (11.1)4 (13.8)8 (17.0)
 ≥1279 (76.4)229 (84.5)14 (77.8)20 (69.0)16 (34.0)
 Missing44 (12.1)12 (4.4)4 (22.2)5 (17.2)23 (48.9)
Visits to doctor before diagnosis
 Referred soon after birth12 (3.3)9 (3.3)2 (6.9)1 (2.1)
 1–1064 (17.5)46 (17.0)6 (33.3)5 (17.3)7 (14.2)
 11–2056 (15.3)45 (16.6)5 (27.8)3 (10.3)3 (6.4)
 21–4068 (18.6)52 (19.2)4 (22.2)8 (27.6)4 (8.5)
 >40123 (33.7)101 (37.3)1 (5.6)8 (27.6)13 (27.7)
 Other22 (6.03)13 (4.8)1 (5.6)3 (10.3)5 (10.6)
Time to diagnosis after testing for PCD
 <1 week45 (12.3)39 (14.4)1 (5.6)1 (3.5)4 (8.5)
 1–4 weeks76 (20.8)61 (22.5)8 (44.4)3 (10.3)4 (8.5)
 1–6 months122 (33.4)105 (38.8)8 (44.4)4 (13.8)5 (10.6)
 6–12 months10 (2.7)8 (3.0)1 (3.5)1 (2.1)
 >1 year28 (7.7)24 (8.9)1 (5.6)2 (6.9)1 (2.1)
 Still waiting28 (7.7)15 (51.7)13 (27.7)
 Not sure36 (9.9)31 (11.4)2 (6.9)3 (6.4)
 Missing20 (5.5)3 (1.1)1 (3.5)16 (34.0)
Diagnostic procedures
 Nasal nitric oxide157 (43.0)110 (40.6)14 (77.8)17 (58.6)16 (34.0)
 Nasal scraping283 (77.5)221 (81.6)16 (88.9)28 (96.6)18 (38.3)
 Bronchoscopy134 (36.7)102 (37.6)6 (33.3)12 (41.4)14 (29.8)
 Genetics134 (36.7)105 (38.8)1 (5.6)13 (44.8)15 (31.9)
 Saccharine test19 (5.2)14 (5.2)1 (5.6)2 (6.9)2 (4.3)
 Nuclear medicine scan (e.g. MRI and CT scans)25 (6.9)19 (7.0)2 (11.1)1 (3.5)3 (6.4)
 Radiography or CT scan alone8 (2.2)2 (0.7)6 (12.8)
 Symptoms only12 (3.3)6 (2.2)6 (12.8)
  • Data are presented as n (%). MRI: magnetic resonance imaging; CT: computed tomography. #: other includes participants still waiting for results and those who received a false-positive result as well as missing value; : median age (interquartile range) 6 (11) years (n=226).